Biotech Distilled
Substack ↗
Subscribe
Subscribe
Substack ↗
About
Research
Areas
Modalities
Phases
Targets
Track record
Movers
The Lead Compound
Home
›
Targets
› Claudin 18.2
Claudin 18.2
(1 companies · 2 programs)
Companies with an active program directed at Claudin 18.2.
Allogene Therapeutics, Inc.
ALLO
ALLO-182
— Gastric Cancer
ALLO-182
— Pancreatic Cancer